Matti Tiainen - 12 Jul 2022 Form 4 Insider Report for MARRONE BIO INNOVATIONS INC

Role
SVP, International Sales
Signature
By Linda V. Moore, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
12 Jul 2022
Net transactions value
$0
Form type
4
Filing time
14 Jul 2022, 21:30:08 UTC
Previous filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBII Common Stock Disposed to Issuer -4,850,521 -100% 0 12 Jul 2022 Direct F1
transaction MBII Common Stock Disposed to Issuer -4,684 -100% 0 12 Jul 2022 By Domestic Partner F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Matti Tiainen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to the Agreement and Plan of Merger, dated as of March 16, 2022, by and between Bioceres Crop Solutions Corp., BCS Merger Sub, Inc. and Issuer (the "Merger Agreement) in exchange for 426,845 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger.
F2 Disposed of pursuant to the Merger Agreement in exchange for 412 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger.